Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
BMC Genomics|December 26, 2018
ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq dataDario Romagnoli, Giulia Boccalini, Martina Bonechi, et al.
Cancer Treatment Reviews|January 17, 2013
Targeting triple negative breast cancer: is p53 the answer?Natalie Turner, Erica Moretti, Olimpia Siclari, et al.
Molecular Oncology|August 25, 2014
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective studyLeonardo Tenori, Catherine Oakman, Patrick G Morris, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|May 19, 2012
Feasibility of evaluating quality cancer care using registry data and electronic health records: a population-based studyAdele Caldarella, Gianni Amunni, Catia Angiolini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracilAngelo Di Leo, David Gancberg, Denis Larsimont, et al.
Molecular Oncology|June 13, 2012
Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot studyLeonardo Tenori, Catherine Oakman, Wederson M Claudino, et al.
BMC Cancer|September 29, 2018
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA projectGiacomo Pelizzari, Grazia Arpino, Laura Biganzoli, et al.
Future Oncology (London, England)|October 11, 2013
TOP2A protein by quantitative immunofluorescence as a predictor of response to epirubicin in the neoadjuvant treatment of breast cancerErica Moretti, Christine Desmedt, Chiara Biagioni, et al.
Breast (Edinburgh, Scotland)|March 13, 2012
Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patientsFrancesca Galardi, Catherine Oakman, Maria Caterina Truglia, et al.
Clinical Breast Cancer|January 21, 2003
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot studyChantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet, et al.
Pageof 18